VIRX Viracta Therapeutics: Company Short-Term Debts

Symbol and logo of brand Viracta (VIRX)

This daily price chart for Viracta Therapeutics (VIRX) reflects the company's dynamics, with a metric of 0.00. The business seeks dominance in the treatment of viral tumors, utilizing a method of activating hidden pathogens to combat lymphomas. Drug production has been outsourced to third-party contractors in the US to minimize infrastructure costs, while raw material supply stability is guaranteed by long-term contracts and flexible routing.

VIRX viracta.com Company Short-Term Loans and Borrowings (07/04/2022 - 02/16/2025)

VIRX (Viracta Therapeutics Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Viracta|VIRX - Consensus Target
- company stock capitalization data:
Market Capitalization Viracta Therapeutics, Inc.|VIRX - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Viracta Therapeutics|VIRX - Accounting Value of Company|Market Cap to Net Assets Ratio viracta.com|VIRX - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Viracta Therapeutics|VIRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Viracta|VIRX - Company Aggregate Debts|Debt to Book Capitalization Ratio Viracta Therapeutics, Inc.|VIRX - Company Long-Term Loans and Borrowings|Company Short-Term Debts Viracta Therapeutics|Quick Liquidity Indicator viracta.com
- earnings and multiples data:
VIRX - Company Net Income
Analysis of all company metrics:VIRX - viracta.com
Manufactured products of Viracta Therapeutics

The implementation of robotic screening systems and software robots for clinical data analysis at Viracta Therapeutics (VIRX) is reflected in the short-term debt history, which records obligations with maturities of up to one year. This indicator aggregates short-term loans and borrowings, allowing for an assessment of liquidity risk and the company's ability to fund its technology stack without the threat of default, which defines the asset's speculative profile.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Current Liabilities CTOR (Citius Oncology, Inc.)|Company Short-Term Debt HURA (tuhurabio.com)|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Short-Term Debt Volume Fate Therapeutics Inc (FATE)|WHWK - Company Short-Term Debt|Company Short-Term Loans and Borrowings TCRX (TScan Therapeutics)|CSBR: Company Short-Term Debts|XBiotech (XBIT) - Company Short-Term Debts|CVM (CEL-SCI Corp.) - Company Short-Term Debts|Company Current Liabilities OS Therapies Inc. (OSTX)|Company Current Liabilities RADX (Radiopharm Theranostics)|Amount of Current Liabilities ARTV|Company Short-Term Debts ANL (Adlai Nortye)|Company Short-Term Debts verupharma.com VERU|TPST: Company Current Liabilities|Company Short-Term Loans and Borrowings XLO (Xilio Therapeutics, Inc.)|RENB (renovarobio.com) - Company Current Liabilities|MURA: Amount of Current Liabilities|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|OKUR: Company Short-Term Loans and Borrowings|Company Short-Term Debts GDTC|CRIS - Short-Term Debt|Company Short-Term Debt Apollomics APLM|Company Short-Term Loans and Borrowings THAR|Advanced Biomed Corp - Company Short-Term Debts|GNPX - Company Short-Term Debts|calidibio.com (CLDI) - Company Short-Term Debt|Current Liabilities SBFM (sunshinebiopharma.com)|XBIO (Xenetic Biosciences Inc.) - Company Short-Term Debts|Short-Term Debt Salarius Pharma SLRX|Company Current Liabilities PPBT (Purple Biotech)|Company Short-Term Debts aoncology.com (AONC)|BeiGene - Company Current Liabilities|Amount of Current Liabilities CKPT (Checkpoint Therapeutics Inc.)|Elevation Oncology - Company Short-Term Debts|Short-Term Debt Volume iCAD, Inc. ICAD|IKNA: Company Short-Term Debts|Company Current Liabilities notablelabs.com|Company Short-Term Debt MorphoSys|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Current Liabilities AAPGV (Ascentage Pharma Group Ltd)